# February 1, 2017

Immco Diagnostics, Inc. Kevin Lawson   
Regulatory Officer   
60 Pineview Dr.   
Buffalo, New York 14031

Re: K163095 Trade/Device Name: Lyme B. Burgdorferi (IgG) MarStripe Test Regulation Number: 21 CFR 866.3830 Regulation Name: Treponema pallidum treponemal test reagents Regulatory Class: Class II Product Code: LSR Dated: September 10, 2016 Received: November 4, 2016

Dear Kevin Lawson:

We have reviewed your Section $5 1 0 ( \mathrm { k } )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting (reporting of

medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and Part 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

# Steven R. Gitterman -S

Uwe Scherf, Ph.D.   
Director   
Division of Microbiology Devices   
Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

Enclosure

20 20 20   
![](images/f197867addf708b6fdd4050345ab95b9241e50558bc37db7fabc26b201358a2e.jpg)
20 20 20 20 20 20 20 20   
20 20   
20   
20 20 20

<table><tr><td>DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use</td><td>Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.</td></tr><tr><td>510(k) Number (if known)</td></tr><tr><td>K163095</td></tr><tr><td>Device Name</td></tr><tr><td></td></tr><tr><td>Lyme B. burgdorferi (IgG) MarStripe Test</td></tr><tr><td></td></tr></table>

# 510(k) Summary of Safety and Effectiveness

This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirement of SMDA 1990 and 21 CFR 807.92.

1. Submitter Name: Address: Phone Number: Contact Person: Summary Prepared:

Immco Diagnostics, Inc. a Trinity Biotech Company   
60 Pineview Dr., Buffalo, NY 14228   
716-691-0091 ext. 110   
Kevin Lawson   
1-4-2017

2. Device Name: Common Name: Product Code:

Lyme B. burgdorferi (IgG) MarStripe Test Lyme B. burgdorferi (IgG) Immunoblot LSR

3. Substantially equivalent to: MarDx B. burgdorferi IgG MarBlot Strip Test System (K950829)

4. Description of device: The kit is an immunoblot method to detect IgG antibodies against B. burgdorferi antigens. The test kit contains:

Nitrocellulose Test Strips with purified B. burgdorferi antigens (10) and quality control lines (3) present in specific positions Sample Diluent. Provided for specimen dilutions. Contains BSA and PBS   
Positive Control derived from human serum positive for Lyme disease. Contains $1 0 . 1 \%$ sodium azide   
Negative Control derived from human serum negative for Lyme disease. Contains $1 0 . 1 \%$ sodium azide   
Conjugate. Antihuman IgG-HRP Conjugate binds reactive antibodies to the Substrate   
TMB Substrate. Provides colorimetric reaction for visual read of bound antibodies   
PBS Wash Buffer concentrate. Removes reagents and unbound antibodies after incubation steps. Must be reconstituted to 1L with distilled or deionized water.

To perform the test, serum or plasma is incubated with individual B. burgdorferi Test Strips. In positive sera antibodies specifically bind to one or more of the test lines on the strip. The strips are washed according to the protocol, and then the pre-diluted, readyto-use Conjugate is added to the test strips. After incubation and wash steps, the ready-to-use Substrate is added to the strips. During a 10 minute $( \pm 4 \mathrm { \ m i n } )$ incubation, conjugate and substrate binding produces visible blue/purple lines for Serum Addition Control (SAC), Conjugate Addition Control (CAC) and Cut-Off Control lines. If the sample is positive for any of the antigen coated test lines, it will show a reaction more intense than the Cut-Off line. Reactions are read visually and reported as positive, negative or equivocal (comparable to Cut-Off line). Strips which have 5 (or more) of the 10 test lines are considered positive for specific IgG antibody to B. burgdorferi.

5. Intended Use: Lyme B. burgdorferi (IgG) MarStripe Test is an immunoblot assay for the in vitro qualitative detection of human IgG antibody to individual proteins of Borrelia burgdorferi in human serum or plasma $\mathsf { K } _ { 2 ^ { - } }$ EDTA) in samples which have been found positive or equivocal using an EIA or IFA test procedure to provide supportive evidence of infection with B. burgdorferi.

6. Similarities and Differences: The Lyme B. burgdorferi (IgG) MarStripe Test was compared to a commercially marketed kit by Trinity Biotech the B. burgdorferi (IgG) MarBlot Strip Test System (K950829). Both kits have the same intended use and use the same methodology except that the MarStripe Test has been validated in plasma $\mathsf { K } _ { 2 ^ { - } }$ EDTA) as well as serum. Both immunoblot kits detect antibodies to B. burgdorferi antigens using the standard immunoblot IgG algorithm. Both assays are qualitative. The MarStripe uses a Horseradish Peroxidase Conjugate and Tetramethylbenzidine (TMB) Substrate/Chromogen in comparison to The MarBlot Alkaline Phosphatase Conjugate and BCIP/NBT Substrate/Chromogen. The MarStripe uses a Cutoff Control line incorporated in the strip in comparison to the 41kD band of Weakly Reactive Control.

7. Non-clinical Tests:

# Reproducibility

Eight specimens were tested by Lyme B. burgdorferi (IgG) MarStripe Test in 4 replicates, two runs per day over 9 days for a total of 72 tests for each specimen at three laboratory sites. Results were read by 2 human operators at each site, equaling a total of 432 read-outs. Samples were selected based on FDA cleared B. burgdorferi ELISA results, including 2 low negative samples, 2 high negative samples, 2 low positive samples and 2 moderate positive samples. Final positive or negative agreement was $100 \%$ for all specimens.

<table><tr><td rowspan=1 colspan=1>ample1      n=432</td><td rowspan=1 colspan=10>R        2    1       2    R    2    2    a</td></tr><tr><td rowspan=1 colspan=1>Low Neg</td><td rowspan=1 colspan=4>Neg.  Neg.  Neg.  Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=5>Neg.  Neg.  Neg.  Neg.  Neg.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=4>0     0     0     0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=5>0     0     0     0     0</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=4>432   432  432   432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=5>432   432   432  432  432</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=4>0%   0%   0%   0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=2 colspan=5>0%   0%   0%   0%   0%</td></tr><tr><td rowspan=1 colspan=1>2    % Positive</td><td rowspan=1 colspan=4></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Low Neg</td><td rowspan=1 colspan=4>Neg.  Neg.  Neg.  Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=5>Neg.  Neg.  Neg.  Neg.  Neg.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=4>0     0     0     0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=5>0     0     0     0     0</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=4>432   432   432   432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=5>432   432   432   432   432</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=4>0%   0%   0%   0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=2 colspan=5>0%   0%   0%   0%   0%</td></tr><tr><td rowspan=1 colspan=1>3    % Positive</td><td rowspan=1 colspan=4></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>High Neg</td><td rowspan=1 colspan=4>Neg.  Neg.  Neg.  Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=3>Neg.  Neg.  Neg.</td><td rowspan=1 colspan=2>Neg.  Neg.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=4>0     0     0     0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=3>0     0     0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=4>432   432  432   432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=3>432   432   432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=4>0%   0%   0%   0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=3>0%   0%   0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>4    % Positive</td><td rowspan=1 colspan=4></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>High Neg</td><td rowspan=1 colspan=4>Neg.  Neg.  Neg.  Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=3>Neg.  Neg.  Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=4>0     0     0     0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=3>0     0     0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>5    % Positive</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Low Pos</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>6    % Positive</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Low Pos</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td></tr><tr><td rowspan=1 colspan=1>7    % Positive</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Moderate Pos</td><td rowspan=1 colspan=1>Wpos.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Cut.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Pos.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=1>412</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>412</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=1>95%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>95%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>8    % Positive</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Moderate Pos</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Neg.</td><td rowspan=1 colspan=1>Pos.</td><td rowspan=1 colspan=1>Neg.</td></tr><tr><td rowspan=1 colspan=1>Band Type</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Positives</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>432</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>432</td></tr><tr><td rowspan=1 colspan=1>Negatives</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>100%</td><td rowspan=2 colspan=1>0%</td></tr><tr><td></td><td></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr></table>

Pos $=$ positive band. Neg $=$ negative band. Wpos $=$ weak positive band. Cut $=$ equivocal band.

Analytical Specificity: 219 sera from healthy blood donors representing endemic and non-endemic geographic regions of the United States were tested. Analytical specificity was determined to be $9 9 . 5 \%$ $9 5 \%$ CI: $9 7 . 1 \% - 1 0 0 \%$ ).

<table><tr><td rowspan=1 colspan=3></td><td rowspan=1 colspan=1>Normal Individuals</td></tr><tr><td rowspan=3 colspan=2>Lyme IgGMarStripeTest</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>e</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>218</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>219</td></tr></table>

Cross-reactivity: A total of 136 potentially cross-reactive specimens from individuals with other autoimmune disorders or infectious conditions were tested on this assay. Positive incidence was $4 . 4 \%$ and all positives specimens by the Lyme B. burgdorferi (IgG) MarStripe Test were confirmed positive when tested by the predicate IgG Western blot device.

<table><tr><td rowspan=1 colspan=1>Population</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>n Positive</td><td rowspan=1 colspan=1>% Positive</td></tr><tr><td rowspan=1 colspan=1>Ehrlichia chafeensis</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Babesia microti</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>40</td></tr><tr><td rowspan=1 colspan=1>Leptospira interrogans</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Helicobacter pylori</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Syphilis</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Influenza</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Rocky Mountain Spotted Fever</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Parvovirus B19</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Systemic lupus erythematosus</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Cytomegalovirus</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Rheumatoid arthritis</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Celiac</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>136</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>4.4</td></tr></table>

Interference: Two Lyme IgG negative and three Lyme IgG positive sera were spiked with hemoglobin $( 2 \tt g / L )$ , unconjugated bilirubin $( 3 4 2 \ \mu \mathrm { m o l / L } )$ , RF $( 1 0 0 ~ \mathrm { | U / m | } )$ , triglycerides $( 3 . 7 ~ \mathrm { m m o l / L } )$ and total cholesterol $( 1 3 \mathrm { \ m m o l / L } )$ and tested using this assay. Samples were tested with and without interfering agents. Qualitative agreement was $100 \%$ for all specimens.

Serum vs. Plasma Matrix Comparison Studies: To establish equivalence of serum vs. plasma ${ \sf K } _ { 2 }$ -EDTA) matrix, 10 pairs of sera/plasma (samples A-J below) were sourced from specimens tested on an FDA cleared Lyme EIA assay. Two of these were Western blot IgG positive, 8 were negative. These specimens were selectively pooled to create another set of 10 samples (samples 1-10 below), including 3 Western blot IgG positives and 7 negatives. These samples were assayed on the Lyme B. burgdorferi (IgG) MarStripe Test. Qualitative agreement for all pairs was $100 \%$ .

<table><tr><td rowspan=1 colspan=1>Sample ID1</td><td rowspan=1 colspan=1>Type{2</td><td rowspan=1 colspan=1>p93</td><td rowspan=1 colspan=1>p66</td><td rowspan=1 colspan=1>p58</td><td rowspan=1 colspan=1>p45</td><td rowspan=1 colspan=1>p41</td><td rowspan=1 colspan=1>p39</td><td rowspan=1 colspan=1>p30</td><td rowspan=1 colspan=1>p28</td><td rowspan=1 colspan=1>p23</td><td rowspan=1 colspan=1>p18</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>Band % PosAgrmt</td><td rowspan=1 colspan=1>Band % NegAgrmt</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>A</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>B</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>c</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>c</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>D</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>E</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>F</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>F</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>G</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>G</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>H</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>H</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>I</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>J</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>J</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>Pool 1 (A+B)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 1 (A+B)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>Pool 2 (B+C)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 2 (B+C)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Pool 3 (C+D)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 3 (C+D)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Pool 4 (D+E)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 4 (D+E)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>POS</td></tr><tr><td rowspan=1 colspan=1>Pool 5 (A+E)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 5 (A+E)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>Pool 6 (F+G)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 6 (F+G)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>Pool 7 (G+H)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 7(G+H)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>Pool 8 (H+l)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 8 (H+l)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>Pool 9 (1+J)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 9 (1+J)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr><tr><td rowspan=1 colspan=1>Pool 10 (F+J)</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td><td rowspan=2 colspan=1>100</td><td rowspan=2 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Pool 10 (F+J)</td><td rowspan=1 colspan=1>Plasma</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>NEG</td></tr></table>

1. Pool 1 to 10 contain a 1:1 mixture of the native samples as indicated. $2 . 0 =$ negative band result. ${ 1 = }$ positive band result.

# 8. Clinical Tests:

Method Comparison: Three sites tested utilized prospectively collected consecutive specimens testing positive on a FDA cleared first-step EIA in the study. 753 specimens were tested on the predicate MarDx B. burgdorferi IgG MarBlot Test device as well as the Lyme B. burgdorferi (IgG) MarStripe Test

<table><tr><td rowspan=2 colspan=2></td><td rowspan=1 colspan=3>Predicate IgG WB</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=3 colspan=1>Lyme IgGMarStripe Test</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>221</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>233</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>503</td><td rowspan=1 colspan=1>520</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>238</td><td rowspan=1 colspan=1>515</td><td rowspan=1 colspan=1>753</td></tr></table>

Positive Agreement: $9 2 . 9 \%$ $9 5 \%$ CI: $8 8 . 6 \%$ - 95.7%) Negative Agreement: $9 7 . 7 \%$ $9 5 \%$ CI: 95.9% - 98.7%)

The 29 discrepant specimens were tested on two additional commercially available B. burgdorferi IgG Western blot methods. Results of the Lyme B. burgdorferi (IgG) MarStripe Test were compared to the consensus (2/3 comparator) results. The 12 positives by MarStripe remained positive by consensus testing and the 17 negatives by MarStripe were found to be positives.

<table><tr><td rowspan=2 colspan=2></td><td rowspan=1 colspan=2>Consensus Result</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=2 colspan=1>Lyme IgGMarStripe Test</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td></tr></table>

Sensitivity: 94 well characterized Lyme disease clinical specimens from the above study were tested with the Lyme B.   
burgdorferi (IgG) MarStripe Test. Specimens included samples from early, early disseminated, and late phases of the disease.   
The sensitivity obtained was compared with that of the predicate device.

<table><tr><td rowspan=2 colspan=1>Interval</td><td rowspan=2 colspan=1>n</td><td rowspan=1 colspan=2>Lyme IgG MarStripeTest</td><td rowspan=1 colspan=2>Predicate IgG WB</td></tr><tr><td rowspan=1 colspan=1>positive</td><td rowspan=1 colspan=1>%</td><td rowspan=1 colspan=1>positive</td><td rowspan=1 colspan=1>%</td></tr><tr><td rowspan=1 colspan=1>Early Lyme (stage 1)</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>18.2</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>13.6</td></tr><tr><td rowspan=1 colspan=1>Early disseminated(stage 2)</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>27.3</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>25.0</td></tr><tr><td rowspan=1 colspan=1>Late Lyme (stage 3)</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>17.9</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>17.9</td></tr><tr><td rowspan=1 colspan=1>Overall</td><td rowspan=1 colspan=1>94</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>19.5</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20.2</td></tr></table>

Sensitivity Comparison:

Lyme B. burgdorferi (IgG) MarStripe Test:   
Predicate device:   
Difference in proportion:

$2 2 . 3 \%$ (21/94) $9 5 \%$ CI: $1 4 . 7 \% - 3 2 . 3 \%$ ) $2 0 . 2 \%$ (19/94) $9 5 \%$ CI: $1 2 . 9 \% - 3 0 . 0 \%$ ) $2 . 1 \%$

CDC Panels: Reference panels from the Center for Disease Control and Prevention (Lyme Disease Validation Panel $\mathsf { n } { = } 1 0$ , Lym Disease Basic Research Panel $\scriptstyle \mathsf { n } = 3 2$ ) were tested on the Lyme B. burgdorferi (IgG) MarStripe Test and the predicate device.

<table><tr><td rowspan=2 colspan=1>Interval</td><td rowspan=2 colspan=1>n</td><td rowspan=1 colspan=2>Lyme IgGMarStripe Test</td><td rowspan=1 colspan=2>Predicate IgG WB</td></tr><tr><td rowspan=1 colspan=1>positive</td><td rowspan=1 colspan=1>%</td><td rowspan=1 colspan=1>positive</td><td rowspan=1 colspan=1>%</td></tr><tr><td rowspan=1 colspan=1>Controls</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Early Lyme (stage 1)</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Early disseminated (stage2)</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Late Lyme (stage 3)</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Overall</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16.7</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>16.7</td></tr></table>

Note: The results are presented as a means to convey further information on the performance of this assay with a masked, characterized serum panel. This does not imply an endorsement of the assay by the CDC.

9. Conclusion: From the performance data and kit comparison above, it is our conclusion that the Lyme B. burgdorferi (IgG) MarStripe Test is substantially equivalent to the B. burgdorferi (IgG) MarBlot Strip Test System (K950829) commercially marketed by Trinity Biotech

![](images/fdc7598831fbdd659371490d3a9e40d0cd5a1ddc3a23fc368ab132d7424c581b.jpg)

Kevin J. Lawson VP Regulatory Affairs